tirzepatide uti risk linked to lower for death, adverse CV and kidney outcomes vs. GLP-1s Can semaglutide cause UTI? What – What are the risks of

*Offer ends 12/31/26

Weight loss effects vary by population, with clinical trials showing up to 21-22% mean weight loss in obesity trials (non-diabetes patients) and lower percentages in type 2 diabetes patients, depending on dose

For some older adults with severe obesity and suitable health status, bariatric surgery may be considered according to NICE guideline CG189 criteria, though age-related surgical risks must be carefully evaluated

It is used in research settings to investigate cytoprotective signaling and tissue-repair mechanisms, including experimentally reported effects in preclinical models relevant to gastrointestinal mucosal integrity, angiogenic signaling, and inflammatory modulation